Procellera™ Composite Antibacterial Wound Dressing is intended for the management of wounds to provide a moist wound environment and is indicated for partial- and full-thickness wounds such as pressure injuries, venous ulcers, diabetic ulcers, first- and second degree burns, surgical incisions, donor and recipient graft sites, etc.

Do not use on individuals with sensitivity or allergy to silver, zinc, or other dressing components.

• Frequent or prolonged use of this product may result, in rare occasions, in temporary discoloration of the skin.
• Caution: Federal law restricts this device to sale by or on the order of a physician.
• Single use only.
• For external use only.
• Gamma irradiation sterilized. Opening the dressing pack compromises the sterile barrier. Do not use if the pouch is open or damaged prior to use.
• Do not apply Procellera™ Composite in conjunction with topical agents such as antimicrobial ointments, enzymatic debriders, antibiotic creams or ointments, silver- or zinc-containing creams, oxidizing agents, or petroleum-based products.
• The use of adhesive dressings on fragile or sensitive skin may pose a risk of skin damage upon removal of the dressing. To mitigate this risk, a skin prep may be applied on the wound perimeter prior to dressing application (not included).
• The patient should stop using the dressing and consult a physician if allergy, irritation, increased pain, maceration, or any irregular skin discoloration occurs.
• Procellera™ Composite is not intended to be used on wounds with uncontrolled bleeding.
• Remove Procellera™ Composite during energy-based procedures (such as radiofrequency, ultrasound, or radiation) where the dressing may interfere with delivery.
• MR unsafe. Remove Procellera™ Composite prior to a MRI or HBOT procedure and apply a new dressing after the procedure.
• Avoid direct dressing contact with electrodes or conductive gels during electronic measurements; eg, EEG or ECG.
• Procellera™ Composite may be used on infected wounds being clinically managed, as an adjunct to the local clinical protocol.
• The safety of daily Procellera™ Composite use for longer than 28 days has not been studied.

The patient should consult a physician if any of the following occur: infection, bleeding, maceration, hypergranulation, irritation at the wound and/or the surrounding skin, or if the wound increases in size.

V.Dox™ Technololgy